Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-004474·Empery Asset Management, LP
Schedule 13G ownership disclosure
X4 Pharmaceuticals Inc
Common Stock, $0.001 par value per share · CUSIP: 98420X202
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Empery Asset Management, LP
Shares: 2,498,162.00 · Class: 9.99%
- Lane Ryan M.
Shares: 2,498,162.00 · Class: 9.99%
- Hoe Martin D.
Shares: 2,498,162.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-004474
- Form type
- SCHEDULE 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- Oct 21, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership